三連板*ST南糖(000911.SZ):舒雅公司醫用口罩業務及僑虹公司熔噴布材料業務不會對公司財務狀況產生重大影響
格隆匯3月9日丨*ST南糖(000911.SZ)公佈,公司股票於2020年3月5日、3月6日、3月9日連續三個交易日漲停。
針對近期新型冠狀病毒疫情,媒體和投資者對公司控股子公司生產口罩需要的醫療級熔噴布材料及生產醫用口罩進行了關注,公司現對相關情況説明如下:
(1)公司控股子公司廣西舒雅護理用品有限公司(“舒雅公司”)是一家個人護理用品生產企業,主營衞生巾、衞生護墊、紙尿布、濕巾等。疫情發生後,應政府要求,舒雅公司進行了技術改造,增加了口罩生產線,3月口罩線投產後,日產口罩預計為10-15萬片,投產初期可以生產一次性普通防護口罩,在取得醫用口罩生產資質後才能生產銷售一次性醫用防護口罩。截至本公告日,舒雅公司醫用口罩尚未正式投入生產,相關生產許可手續正在辦理中。
(2)公司控股子公司南寧僑虹新材料股份有限公司(“僑虹公司”)新投產的孖紡高分子吸附新材料生產線2018年開始建設,主要用於生產孖紡濾材產品如:濕巾、面膜基布工業擦拭紙等,孖紡濾材產品的設計產能為8500噸。疫情發生後,僑虹公司應政府的要求,通過技術改造和工藝調整,改造為可生產口罩需要的醫療級熔噴布材料的生產線,產品由政府收儲,生產醫用熔噴布產能較低,目前熔噴布日產量約2噸,預計年產量約800噸。
舒雅公司醫用口罩業務及僑虹公司的熔噴布材料業務不會對公司財務狀況產生重大影響,請注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.